Thank you for joining us at CPHI Shanghai 2025!
At CPHI Shanghai 2025, we met with 50+ enterprise representatives from countries including South Korea, India, Vietnam, Pakistan, Belarus, Ukraine, Switzerland, Brazil, and Colombia etc.
We look forward to building strategic collaborations with more partners in the API & FDF space. Let's drive innovation & growth together!
Heron Pharma will extend the listed exhibitions in the second half of 2025：
● CPHI Korea (Booth: H30)
Date: Aug 26-28
Location: COEX, Seoul, Korea
● CPHI Frankfurt (Booth: 11.0A69)
Date: Oct 28-30
Location: Messe Frankfurt Germany
● API China
Date: Nov 12-14
Location: CQIEC Chongqing, China
Looking forward to meeting you!
Best-selling Product:
Alfacalcidol (CEP-2024-060/KDMF 20250602 -211-J-1904)
Japanese Name: アルファカルシドール
USP/EP Name: Alfacalcidol
CAS No. 41294-56-8
● Alfacalcidol is indicated for the treatment of osteoporosis, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets and osteomalacia.
Recommended dosage: 0.25 to 0.5 μg once daily.
● This product from Heron Pharma complies with USP, EP and ChP.
Calcipotriene (US DMF 038743, A)
Japanese Name: カルシポトリオール
USP Name: Calcipotriene
EP Name: Calcipotriol Monohydrate
CAS No. 147657-22-5
● Calcipotriene is a first-line therapeutic agent for plaque psoriasis (psoriasis vulgaris), it demonstrates favorable long-term tolerability and sustained therapeutic efficacy.
● This product from Heron Pharma complies with USP, EP and BP.
Post time: Aug-04-2025